FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2552023441> ?p ?o ?g. }

• W2552023441 endingPage "792" @default.
• W2552023441 startingPage "785" @default.
• W2552023441 abstract "To evaluate the long-term effectiveness and safety of the adjustable transobturator male system (ATOMS® , Agency for Medical Innovations A.M.I., Feldkirch, Austria) in a European-wide multicentre setting.In all, 287 men with stress urinary incontinence (SUI) were treated with the ATOMS device between June 2009 and March 2016. Continence parameters (daily pad test/pad use), urodynamics (maximum urinary flow rate, voiding volume, residual urine), and pain/quality of life (QoL) ratings (visual analogue scale/Leeds Assessment of Neuropathic Symptoms and Signs, International Consultation on Incontinence Questionnaire-Short Form [ICIQ-SF]/Patient Global Impression of Improvement [PGI-I]) were compared preoperatively and after intermediate (12 months) as well as after individual maximum follow-up. Overall success rate, dry rate (<10 mL/day and 0-1 pad/day), device durability, treatment failure, and device complications were recorded. Nonparametric tests were used for statistical analyses.After a median (interquartile range [IQR]) follow-up of 31 (10-54) months and a median (IQR) of 3 (2-4) adjustments, the overall success rate was 90% (258 men) and the dry rate was 64% (184). Daily pad test and pad use decreased from a median of 400 mL/day and 4 pads/day to a median of 18 mL/day and 1 pad/day (both P < 0.001), concomitantly QoL ratings significantly improved and changed to a high level of satisfaction (PGI-I 4 to 2, ICIQ-SF 17 to 5; both P < 0.001). The UI results at 12 months were comparable to those at final follow-up. Chronic pain and intraoperative complications did not occur. Most of the postoperative complications were Clavien-Dindo grade I-III (no grade IV or V). At present, 231 (80%) of all the ATOMS devices are still functioning; 56 (20%) were removed, the most common reason being local titanium intolerance (41%) and leak/dysfunction (30%). The operating time and continence outcome varied between port generations. In this regard the latest port generation (silicone-covered scrotal port) was superior to its predecessors. Primary implantation (P = 0.002), good physical health (P = 0.001), and no history of radiotherapy (P < 0.001) were prognostic factors for beneficial treatment outcome.The ATOMS device is safe and shows high treatment efficacy and patient satisfaction in the largest cohort study to date. The latest generation, with its pre-attached silicone-covered scrotal port, is superior to its predecessors. Significantly better results were achieved with primary implantation and in those without a history of radiotherapy." @default.
• W2552023441 created "2016-11-30" @default.
• W2552023441 creator A5033240118 @default.
• W2552023441 creator A5043049642 @default.
• W2552023441 creator A5044524026 @default.
• W2552023441 creator A5051303155 @default.
• W2552023441 creator A5053922377 @default.
• W2552023441 creator A5060515960 @default.
• W2552023441 creator A5067247186 @default.
• W2552023441 creator A5070880290 @default.
• W2552023441 date "2016-11-21" @default.
• W2552023441 modified "2023-10-05" @default.
• W2552023441 title "Long-term outcome of the adjustable transobturator male system (ATOMS): results of a European multicentre study" @default.
• W2552023441 cites W1219258675 @default.
• W2552023441 cites W1548810375 @default.
• W2552023441 cites W1578649580 @default.
• W2552023441 cites W1586525339 @default.
• W2552023441 cites W1761382225 @default.
• W2552023441 cites W1816774700 @default.
• W2552023441 cites W1946670364 @default.
• W2552023441 cites W1968287077 @default.
• W2552023441 cites W1977720261 @default.
• W2552023441 cites W2019342718 @default.
• W2552023441 cites W2030119084 @default.
• W2552023441 cites W2044039422 @default.
• W2552023441 cites W2054450921 @default.
• W2552023441 cites W2096998881 @default.
• W2552023441 cites W2101001966 @default.
• W2552023441 cites W2114836934 @default.
• W2552023441 cites W2117485892 @default.
• W2552023441 cites W2122824000 @default.
• W2552023441 cites W2132823819 @default.
• W2552023441 cites W2134759117 @default.
• W2552023441 cites W2165109763 @default.
• W2552023441 cites W2165358428 @default.
• W2552023441 cites W2170285703 @default.
• W2552023441 cites W2274270036 @default.
• W2552023441 cites W2278574344 @default.
• W2552023441 cites W2298974936 @default.
• W2552023441 cites W2300476913 @default.
• W2552023441 cites W2304767321 @default.
• W2552023441 cites W2313355910 @default.
• W2552023441 doi "https://doi.org/10.1111/bju.13684" @default.
• W2552023441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27868328" @default.
• W2552023441 hasPublicationYear "2016" @default.
• W2552023441 type Work @default.
• W2552023441 sameAs 2552023441 @default.
• W2552023441 citedByCount "68" @default.
• W2552023441 countsByYear W25520234412017 @default.
• W2552023441 countsByYear W25520234412018 @default.
• W2552023441 countsByYear W25520234412019 @default.
• W2552023441 countsByYear W25520234412020 @default.
• W2552023441 countsByYear W25520234412021 @default.
• W2552023441 countsByYear W25520234412022 @default.
• W2552023441 countsByYear W25520234412023 @default.
• W2552023441 crossrefType "journal-article" @default.
• W2552023441 hasAuthorship W2552023441A5033240118 @default.
• W2552023441 hasAuthorship W2552023441A5043049642 @default.
• W2552023441 hasAuthorship W2552023441A5044524026 @default.
• W2552023441 hasAuthorship W2552023441A5051303155 @default.
• W2552023441 hasAuthorship W2552023441A5053922377 @default.
• W2552023441 hasAuthorship W2552023441A5060515960 @default.
• W2552023441 hasAuthorship W2552023441A5067247186 @default.
• W2552023441 hasAuthorship W2552023441A5070880290 @default.
• W2552023441 hasConcept C119060515 @default.
• W2552023441 hasConcept C141071460 @default.
• W2552023441 hasConcept C14184104 @default.
• W2552023441 hasConcept C159110408 @default.
• W2552023441 hasConcept C1862650 @default.
• W2552023441 hasConcept C2775944032 @default.
• W2552023441 hasConcept C2778531004 @default.
• W2552023441 hasConcept C2779951463 @default.
• W2552023441 hasConcept C71924100 @default.
• W2552023441 hasConceptScore W2552023441C119060515 @default.
• W2552023441 hasConceptScore W2552023441C141071460 @default.
• W2552023441 hasConceptScore W2552023441C14184104 @default.
• W2552023441 hasConceptScore W2552023441C159110408 @default.
• W2552023441 hasConceptScore W2552023441C1862650 @default.
• W2552023441 hasConceptScore W2552023441C2775944032 @default.
• W2552023441 hasConceptScore W2552023441C2778531004 @default.
• W2552023441 hasConceptScore W2552023441C2779951463 @default.
• W2552023441 hasConceptScore W2552023441C71924100 @default.
• W2552023441 hasIssue "5" @default.
• W2552023441 hasLocation W25520234411 @default.
• W2552023441 hasLocation W25520234412 @default.
• W2552023441 hasOpenAccess W2552023441 @default.
• W2552023441 hasPrimaryLocation W25520234411 @default.
• W2552023441 hasRelatedWork W2013779571 @default.
• W2552023441 hasRelatedWork W2047967234 @default.
• W2552023441 hasRelatedWork W2061253854 @default.
• W2552023441 hasRelatedWork W2412218867 @default.
• W2552023441 hasRelatedWork W2439875401 @default.
• W2552023441 hasRelatedWork W2909252410 @default.
• W2552023441 hasRelatedWork W2953680460 @default.
• W2552023441 hasRelatedWork W2973108776 @default.
• W2552023441 hasRelatedWork W4220774673 @default.
• W2552023441 hasRelatedWork W4245524627 @default.
• W2552023441 hasVolume "119" @default.

• next